Halma plc (LON:HLMA - Get Free Report) insider Steve Gunning purchased 267 shares of the firm's stock in a transaction that occurred on Thursday, March 27th. The stock was bought at an average cost of GBX 2,619 ($33.84) per share, for a total transaction of £6,992.73 ($9,034.53).
Halma Price Performance
LON:HLMA traded up GBX 51 ($0.66) during mid-day trading on Tuesday, reaching GBX 2,632 ($34.01). 544,522 shares of the company were exchanged, compared to its average volume of 1,415,569. The company has a quick ratio of 1.51, a current ratio of 2.45 and a debt-to-equity ratio of 45.83. The stock has a market cap of £9.91 billion, a PE ratio of 36.82, a PEG ratio of 2.93 and a beta of 0.53. Halma plc has a 12 month low of GBX 2,143 ($27.69) and a 12 month high of GBX 3,094 ($39.97). The company has a fifty day moving average of GBX 2,816.41 and a 200 day moving average of GBX 2,690.98.
Analyst Upgrades and Downgrades
HLMA has been the topic of several recent analyst reports. JPMorgan Chase & Co. upgraded shares of Halma to a "neutral" rating and set a GBX 2,600 ($33.59) target price on the stock in a research note on Friday, December 6th. Shore Capital restated a "hold" rating on shares of Halma in a research report on Thursday, March 13th. Finally, Berenberg Bank raised their price objective on shares of Halma from GBX 2,450 ($31.65) to GBX 2,700 ($34.88) and gave the stock a "hold" rating in a report on Thursday, December 5th. Four research analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of "Hold" and a consensus price target of GBX 2,587.50 ($33.43).
View Our Latest Stock Analysis on Halma
Halma Company Profile
(
Get Free Report)
Halma is a global group of life-saving technology companies, focused on growing a safer, cleaner, healthier future for everyone, every day. Its purpose defines the three broad markets it operates in:
- Safety - Protecting people's safety and the environment as populations grow, and enhancing worker safety.
- Environment - Addressing the impacts of climate change, pollution and waste, protecting life-critical resources and supporting scientific research.
- Health - Meeting the increasing demand for better healthcare as chronic illness rises, driven by growing and ageing populations and lifestyle changes.
Halma employs over 8,000 people in more than 20 countries, with major operations in the UK, Mainland Europe, the USA and Asia Pacific.
Featured Articles
Before you consider Halma, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Halma wasn't on the list.
While Halma currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.